Frontiers in medicine · 2026
Is there a benefit to adding dexamethasone to levobupivacaine in ultrasound-guided adductor canal block following anterior cruciate ligament reconstruction?
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sreckovic Svetlana, Vukman Petar, Klacar Radmila, Odalovic Ana, Jovanovic Vesna, Bilanovic Miljan, Milovanovic Darko
Аннотация
BACKGROUND: Reconstruction of the anterior cruciate ligament (ACL) often causes severe postoperative pain. This study aimed to assess how dexamethasone affects the analgesic effectiveness of the adductor canal block (ACB), opioid use, and rebound pain after ACL reconstruction with a bone-patellar tendon-bone (BPTB) graft.
METHODS: This non-randomized prospective study analyzed a total of 160 patients, who were divided into two groups: the Dexamethasone + ACB group and the ACB group.
RESULTS: Within the first 24 h after surgery, there was no difference between the groups in the percentage of patients experiencing pain (73.75% vs. 85%; χ 2 = 2.4433; p = 0.118) or in pain severity during activity (1.74 ± 0.97 vs. 1.59 ± 0.65; p = 0.779). During the first 48 h after surgery, no significant difference was observed in opioid use between the groups. Three patients in the non-dexamethasone group reported rebound pain (χ 2 = 0.2564; p = 0.61), while blood glucose levels were significantly higher in the dexamethasone group (χ 2 = 4.329; p = 0.037).
CONCLUSION: The addition of dexamethasone to the local anesthetic during ACB after ACL reconstruction is not supported due to the lack of benefits related to postoperative pain levels and the associated increase in glucose levels.
METHODS: This non-randomized prospective study analyzed a total of 160 patients, who were divided into two groups: the Dexamethasone + ACB group and the ACB group.
RESULTS: Within the first 24 h after surgery, there was no difference between the groups in the percentage of patients experiencing pain (73.75% vs. 85%; χ 2 = 2.4433; p = 0.118) or in pain severity during activity (1.74 ± 0.97 vs. 1.59 ± 0.65; p = 0.779). During the first 48 h after surgery, no significant difference was observed in opioid use between the groups. Three patients in the non-dexamethasone group reported rebound pain (χ 2 = 0.2564; p = 0.61), while blood glucose levels were significantly higher in the dexamethasone group (χ 2 = 4.329; p = 0.037).
CONCLUSION: The addition of dexamethasone to the local anesthetic during ACB after ACL reconstruction is not supported due to the lack of benefits related to postoperative pain levels and the associated increase in glucose levels.